ABSTRACT
Introduction
The growing market demand for cosmetic facial enhancement and rejuvenation procedures with minimal down time and low risk, has led to the development of methods for non-surgical skin rejuvenation.
Laser skin resurfacing was first introduced in the mid 1990's to precisely remove the upper layers of photo damaged, aged skin as an alternative to chemical peels. While enabling impressive clinical results, the first generation of laser resurfacing systems were associated with prolonged healing and high complication rates, particularly in darker skin patients [1, 2] . These limitations resulted from the fact that the entire epidermis and papillary dermis were removed, often over large skin areas such as the entire face.
A new generation of laser resurfacing systems was introduced in 2003 with the development of a fractional laser (Reliant) [3, 4] . Instead of treating an entire skin area, this laser treats a condensed matrix of small "islets" of tissue leaving intact skin in-between these islets. Healing is immediately initiated from these intact skin areas resulting in reduced downtime and reduced complications. Since the introduction of this first fractional laser system, a myriad of "fractional" laser systems, mostly based on CO 2 and Erbium YAG laser technology, have been developed and cleared for marketing worldwide [5] .
RF energy is a form of electromagnetic energy. When applied to tissue, rapidly oscillating electromagnetic fields cause movement of charged particles within the tissue and the resultant molecular motion generates heat. This source of heat has been extensively used in surgery for hemostasis and tissue ablation (electro-surgery). In the past decade RF has been widely applied in the field of aesthetics for various indications based on skin tightening generated by deep RF dermal heating with resultant collagen remodeling [6] [7] [8] .
In the past several years, several fractional RF systems have been introduced that allow controlled fractional skin resurfacing, similar to the results achieved with various laser systems. In addition to the epidermal effect, fractional RF systems allow enhancement of the dermal layer thus contributing to a combined effect leading to an effective micro-ablative skin resurfacing and improved appearance of wrinkles, fine lines and acne scars.
The novel TriFractional approach using the new TriFractional applicator from Pollogen ® is designed to enable fractional skin resurfacing and treatment of wrinkles via controlled epidermal micro-ablation and concomitant dermal remodeling with a long established, highly reliable, and cost-effective technology. Treatment with the new TriFractional applicator can be also done as part of a combination procedure, the TriLipo MED ™ procedure, custom tailored to the patient, using additional technologies, TriLipo RF and TriLipo DMA, incorporated in the same device, the multi-application Maximus ™ system. The current research was intended to evaluate the safety and effectiveness of the novel TriFractional technology and applicator for skin resurfacing and treatment of wrinkles.
Methods

TriFractional Technology
The TriFractional applicator is indicated for skin resurfacing and the treatment of wrinkles by means of micro-ablation and coagulation. The TriFractional applicator is one of the modules on the Maximus system. A disposable treatment tip, containing a matrix of bi-polar electrode pins, is attached to the distal end of the applicator and is placed on the skin for treatment. TriFractional RF energy is delivered to the skin in a fractional manner via an array of multi-electrode pins.
Radiofrequency current is delivered sequentially between each of the pin electrodes and the large electrode which surrounds the pin matrix. Due to this design, relatively high RF current densities are formed in the tissue under each pin electrode, resulting in localized fractional treatment micro-wounds in the epidermis which are in direct contact with the electrodes while heat is delivered deeper into the dermis. This fractional manner of energy delivery leaves intact zones in between the targeted areas which serve as a reservoir of healthy cells to promote faster, more effective wound healing.
The TriFractional technology emits a "train" of three fractional sub-pulses spaced by very short pauses of Thermal Relaxation Time (TRT), in one treatment pulse. This modality enables to achieve an enhanced effect of deeper penetration and optimized efficacy, with less discomfort to the patient and a deeper gradual thermal effect.
Shortly after treatment there is moderate skin erythema and edema in the treated zone, which resolves within 1 -3 days.
During the healing phase, small pin-point epidermal crusts appear at each micro-ablated spot. These crusts exfoliate naturally after a few days leading to mild epidermal resurfacing. In the dermis, treatment induces remodeling of dermal collagen (neocollagenesis) and of other matrix molecules, leading to dermal renewal.
Clinical Methods
A clinical evaluation was conducted treating healthy volunteers in order to assess the safety and efficacy of the TriFractional technology. The subjects were treated for various aesthetic reasons such as treatment of wrinkles, acne scars and un-even skin complexion.
The protocol included 2 or more (according to treated skin condition) treatments with the TriFractional applicator at four weeks interval.
In addition, selected subjects were treated using the TriLipo Med ™ procedure which includes: The addition of the TriLipo technology which combines TriLipo focused RF and DMA resulted in enhanced improvement of skin texture, toning and tightening. The TriLipo RF thermal effect stimulates collagen production while DMA is essential in improving lymphatic drainage and reducing edema.
Prior to treatment a medical history was taken to exclude any contraindication such as pregnancy, any implantable electronic device that could be disrupted by RF energy and any active dermatological or collagen-vascular disorder. Patients signed an informed consent form.
Topical anesthesia (Emla, AstraZeneca) was used on some of the subjects prior to the treatment according to the manufacturer instructions. The decision whether or not to use an anesthetic on treatment area was made by the physician based on size or sensitivity of the treatment area, treatment parameters and the subject's reported general tolerance.
The face was thoroughly cleaned and the treatment was performed only after the skin was completely dry.
One treatment of the TriFractional applicator with a high power pulse (150 msec) was performed.
Subjects were provided with a "patient-controlled manual switch" which enabled them to stop the treatment should they experience significant discomfort. The TriFractional treatment parameters for each subject were defined according to the area being treated and the severity of the condition. During the first visit, the first few pulses were of low power level, in order to assess the immediate results. Once the initial skin response was assessed the physician decided on the power level according to subject's skin condition.
Subjects were asked to provide feedback regarding the pain level during treatment and were also questioned about the recovery process following each TriFractional treatment. Typically erythema and edema appeared and lasted for 1 -3 days. A fractional eschar (matrix) pattern typically appeared 1 to 2 days post treatment and lasted 3 days to one week, depending on the skin characteristics and treatment strength. Subjects were instructed to use sun screen continuously to avoid risk of pigmentary changes.
Histology
To demonstrate the TriFractional effect on epidermal and dermal skin layers, preliminary tests were performed on porcine skin followed by comprehensive in-vivo and exvivo histological examinations.
Porcine Skin
Fresh porcine abdomen and ear skin samples were exposed to different TriFractional energy levels.
In-Vivo Human Abdominal Skin
One abdominal patient consented to a series of TriFractional pulses prior to her scheduled mini abdominoplasty. Pulses of the High power default settings (160 msec) were performed at one week and one day before the surgery. Skin samples of treated and untreated control area were taken from this patient during her abdominoplasty procedure for histological analysis. Formalin fixed, paraffin embedded sections were prepared and stained with H&E for pathological examination by Patho-Lab Diagnostics Ltd., Nes Ziona, Israel. Pathological examination was performed by Andrea Gat, M.D., Head of Dermatopathology Unit, Sourasky Medical Center, Tel Aviv, Israel.
Ex-Vivo Human Skin Study
The Gredeco ex vivo skin model for maintaining skin fragments (harvested from donors undergoing plastic surgery) in survival condition and artificially aging by Ultraviolet (UV) irradiation, was used as previously described by Boisnic and Branchet [7] .
• Histological modifications of the skin were analyzed at different intervals between Day 0 (D0) and Day 10 (D10), using H&E staining.
• Immunohistochemical analysis of mitotic index of the epidermis was done on D2. An antibody Ki67 (Dako, clone MIB-1, marker cells in the M, S, G1, G2 phases of the cell cycle) was used. The immunodetection was made with an indirect technique of immunoperoxydase in 4 levels, amplified (kit DAKO) and stained in red by AEC (3-amino-9-ethylcarbazole).
The results were expressed in % of positive epithelial cells.
• Morphometrical analysis of collagen fibers was done at D10. Serial sections of 4 µm thickness were obtained and specifically stained with a picric acid solution containing 0.1% Sirius red. Collagen was analyzed by computerized morphometrical analysis. For a quantitative analysis of these macromolecules, a computerized image analysis of each section was made. The stained slides were examined using a microscope (Leitz) (magnification ×160) connected with a camera unit (XC-75 CE type) and a microprocessor (Q520).
The surface of collagen bundles were measured in µm 2 and the relative collagen content of the dermis was then expressed as a percentage. For both the analyses of epidermal mitotic index and quantitative collagen content, samples with more than one pulse on the same area were included to amplify the reaction comparing to control samples.
Statistical Analysis
The statistical significance of changes recorded was determined using the Student's t-test when p < 0.05 was considered as statistically significant.
Results
TriFractional Facial Treatments Results
The results of the TriFractional treatments included reduction of fine wrinkles, improved appearance of acne scars, a general improvement of skin texture and scar tissue, skin brightening, skin tightening, improvement of skin irregularities and reduction in pore size. The subjects treated with the TriLipo Med procedure displayed an additional facial contouring effect especially visible on the jaw-line area.
No significant undesired effects were experienced by the subjects and they reported a tolerable pain level. All subjects expressed satisfaction with the clinical results. Figures 1 -3 demonstrate results of TriFractional treat-treatment. ments. Figure 1 shows impressive peri-oral wrinkles improvement after two TriFractional treatments. The subjects underwent treatments with the TriFractional applicator on selected problematic areas, and additional complementary treatments with the TriLipo RF and DMA applicator on the entire face. Results indicate a significant facial contouring in lower cheeks and jaw line as well as improvement of wrinkles and acne scars. These results clearly demonstrate the additive value of the unique TriLipo MED procedure, combining TriFractional, TriLipo RF and TriLipo DMA technologies for facial skin rejuvenation and facial contouring.
Histological Results
Porcine Skin Histologies for Preliminary
Evaluation In all treated porcine skin samples there is thermal injury in the epidermis alone or up to and including the upper dermis, depending on the treatment parameters and thickness of skin fragment. The epidermal changes are characterized by elongation of nuclei, and by epidermal necrosis to various extents. The dermal changes are characterized by condensation in the dermal connective tissue.
Depth of injury is in direct correlation to the energy level used. In samples from abdomen skin treated with low power, epidermal injury was the least prominent and only the basal lower spinous epidermis layer was involved and the dermis was spared. The epidermal changes in this series were focal with skip area of normal epidermis in between the involved foci. All the other series showed both epidermal and dermal injury correlated with the level of energy in terms of depth and width. The ear skin samples are significantly more sensitive compared to abdomen skin samples, and even at low energy levels, there are areas of significant damage.
The histological results of the effect of varying power levels on the porcine skin emphasize the importance of careful selection of the treatment parameters. 
In Vivo Human Abdominal Skin
Samples taken one day after treatment showed epidermal necrosis in the involved area and an affect on the papillary as well as upper reticular dermal collagen areas. Skip areas are visible between affected areas. Neutrophilic infiltrate was present (Figure 9) .
Samples taken 1 week after treatment show intact (regenerated) epidermis in foci covered with scale crust (sign of previous damage). Dermal collagen affected areas are demonstrated. Minimal lymphocytic infiltrate was present (Figure 10). 
Ex-Vivo Human Skin Study
Histologies show epidermal modifications with a modified or necrotic appearance within 3 quarters of the epidermis or within all of the epidermis. In other cases, limited destruction of the epidermis was found with seconddary elimination of the necrosis shaped zone appearing as a squamous crust. In even rarer cases, alterations were very moderate, with condensed or vacuous spaces observed in the cytoplasm of the keratinocytes.
From D3 to D10 partial reparation was observed with the elimination of the crust (parakeratosis zone and necrotic debris), and regeneration of the basal cell layer under the modified epithelial zone (Figure 11). 
Evaluation of Mitotic Index of Epidermis
The immunodetection realized just adjacent to the RF treatment zones using antibody Ki67 revealed a statistically significant augmentation of positive epithelial cells (Figure 12) . The percent of these mitotic cells rose from an average of 3.07% ± 1.57% in experimentally aged skin to 8.9% ± 3.03% in the skin treated by TriFractional RF (p = 0.0017). This represents an increase of nearly 3 times the amount of positive epithelial cells between experimentally aged skin and experimentally aged skin treated by fractional RF. 
Discussion and Conclusions
During the past years, the fractional treatment concept became trendy as it offers a controlled skin treatment of specific tiny areas with enhanced healing through the surrounding untreated areas. Extensive attempts have been made to investigate the clinical and histopathologycal effects of fractional energy sources on dermal and epidermal structures.
Several fractional RF systems have recently been cleared for marketing based on published clinical results with these RF fractional systems [9] [10] [11] .
Hruza et al. [9] evaluated the effect of a fractional RF applicator (Matrix ™ RF by Syneron) for skin rejuvenation and wrinkle reduction. Their histological findings, immediately post-treatment, revealed demarcated zones of ablation/coagulation/necrosis and subnecrosis up to a depth of 450 micron. Higher energy levels generated deeper effects. Subjects undergoing facial treatment had minimal pain, no permanent side effects, or significant downtime. The investigators' assessment of improvement in skin texture was greater than 40% for approximately 50% of subjects. Higher energy levels and lower coverage rates produced better aesthetic results along with less pain. They concluded that RF fractional skin resurfacing results in a safe, tolerable and effective improvement in skin texture and reduction of wrinkles. The depth of tissue ablation, coagulation and necrosis and the relative proportions of these phenomena were found to be controllable and could be modulated to optimize treatment of variable dermatologic conditions.
Another study [10] further evaluating the effect of the eMatrix ™ system by Syneron, confirmed that the treatment improved skin appearance while addressing some of the limitations of ablative resurfacing and non ablative skin rejuvenation. Authors reported that unlike fractional ablative laser treatments, which mostly affect the epidermis, the sublative technique has less impact on the epidermis and most of the effect is in the dermis. They concluded that healing is rapid and downtime is minimal thus treatment is appropriate for all skin types and is an effective alternative for patients with darker skin.
The current study demonstrates the safety and efficacy of the novel fractional RF technology, the TriFractional. The evaluation provides clinical and histological evidence supporting the TriFractional being a promising technology for skin rejuvenation, treatment of wrinkles and acne scars and for general improvement of skin texture, with minimal down time and minimal discomfort to the patient. Histological results confirmed the TriFractional impact on epidermal renewal and dermal regeneration and demonstrated the biological mechanism of the effect. Immediate effect as well as effect following a few days was demonstrated in various histological models, while exvivo results support the in-vivo findings. Combining the TriFractional treatment with intermediate TriLipo RF and TriLipo DMA using the TriLipo MED Procedure, enhances facial toning and enables a holistic approach to facial rejuvenation and enhancement.
In summary, the fractional mode of the treatment enables a faster, more effective healing process, eliminating patient downtime resulting in a safe, tolerable, effective skin rejuvenation. 
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